188 related articles for article (PubMed ID: 23445872)
1. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
[TBL] [Abstract][Full Text] [Related]
4. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
[TBL] [Abstract][Full Text] [Related]
5. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
[TBL] [Abstract][Full Text] [Related]
6. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
7. Mutations of
Schmidt J; Ramis-Zaldivar JE; Nadeu F; Gonzalez-Farre B; Navarro A; Egan C; Montes-Mojarro IA; Marafioti T; Cabeçadas J; van der Walt J; Dojcinov S; Rosenwald A; Ott G; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
Blood; 2017 Jul; 130(3):323-327. PubMed ID: 28533310
[TBL] [Abstract][Full Text] [Related]
8. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
[TBL] [Abstract][Full Text] [Related]
9. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
Launay E; Pangault C; Bertrand P; Jardin F; Lamy T; Tilly H; Tarte K; Bastard C; Fest T
Leukemia; 2012 Mar; 26(3):559-62. PubMed ID: 21941365
[No Abstract] [Full Text] [Related]
10. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
[TBL] [Abstract][Full Text] [Related]
11. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
Salaverria I; Philipp C; Oschlies I; Kohler CW; Kreuz M; Szczepanowski M; Burkhardt B; Trautmann H; Gesk S; Andrusiewicz M; Berger H; Fey M; Harder L; Hasenclever D; Hummel M; Loeffler M; Mahn F; Martin-Guerrero I; Pellissery S; Pott C; Pfreundschuh M; Reiter A; Richter J; Rosolowski M; Schwaenen C; Stein H; Trümper L; Wessendorf S; Spang R; Küppers R; Klapper W; Siebert R; ; ;
Blood; 2011 Jul; 118(1):139-47. PubMed ID: 21487109
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
[TBL] [Abstract][Full Text] [Related]
13. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.
Salmeron-Villalobos J; Egan C; Borgmann V; Müller I; Gonzalez-Farre B; Ramis-Zaldivar JE; Nann D; Balagué O; López-Guerra M; Colomer D; Oschlies I; Klapper W; Glaser S; Ko YH; Bonzheim I; Siebert R; Fend F; Pittaluga S; Campo E; Salaverria I; Jaffe ES; Quintanilla-Martinez L
Blood Adv; 2022 Aug; 6(16):4661-4674. PubMed ID: 35609565
[TBL] [Abstract][Full Text] [Related]
14. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
15. The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.
Zamò A; Pischimarov J; Horn H; Ott G; Rosenwald A; Leich E
Br J Haematol; 2018 Feb; 180(3):391-394. PubMed ID: 29193015
[TBL] [Abstract][Full Text] [Related]
16. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract][Full Text] [Related]
17. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.
Kotsiou E; Okosun J; Besley C; Iqbal S; Matthews J; Fitzgibbon J; Gribben JG; Davies JK
Blood; 2016 Jul; 128(1):72-81. PubMed ID: 27103745
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of
Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
[No Abstract] [Full Text] [Related]
19. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
20. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique.
Lestou VS; Gascoyne RD; Salski C; Connors JM; Horsman DE
Genes Chromosomes Cancer; 2002 Jun; 34(2):201-10. PubMed ID: 11979554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
